Waist-to-hip ratio but not body mass index predicts liver cirrhosis in women

References

• Blachier M, Leleu H, Peck-Radosavljevic M, et al. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593–608.
   PubMed Web of Science ®Google Scholar
• Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313:2263–2273.
   PubMed Web of Science ®Google Scholar
• Charlton M, Kasparova P, Weston S, et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl. 2001;7:608–614.
   PubMed Web of Science ®Google Scholar
• Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol. 2003;98:2042–2047.
   PubMed Web of Science ®Google Scholar
• Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705–1725.
   PubMedGoogle Scholar
• Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology. 2000;32:689–692.
   PubMed Web of Science ®Google Scholar
• Marmur J, Bergquist A, Stal P. Liver transplantation of patients with cryptogenic cirrhosis: clinical characteristics and outcome. Scand J Gastroenterol. 2010;45:60–69.
   PubMed Web of Science ®Google Scholar
• Marrero JA, Fontana RJ, Su GL, et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002;36:1349–1354.
   PubMed Web of Science ®Google Scholar
• Reeves HL, Zaki MY, Day CP. Hepatocellular carcinoma in obesity, type 2 diabetes, and NAFLD. Dig Dis Sci. 2016;61:1234–1245.
   PubMed Web of Science ®Google Scholar
• Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am J Med Sci. 2006;331:166–174.
   PubMed Web of Science ®Google Scholar
• Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology. 2007;132:2087–2102.
   PubMed Web of Science ®Google Scholar
• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–781.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) [Internet]. Obesity and overweight. Geneva: WHO; 2016. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
   Google Scholar
• Zhang C, Rexrode KM, van Dam RM, et al. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. 2008;117:1658–67.
   PubMed Web of Science ®Google Scholar
• Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359:2105–2120.
   PubMed Web of Science ®Google Scholar
• Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond). 2010;34:949–959.
   PubMed Web of Science ®Google Scholar
• Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut. 2010;59:1410–1415.
   PubMed Web of Science ®Google Scholar
• Raynard B, Balian A, Fallik D, et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology. 2002;35:635–638.
   PubMed Web of Science ®Google Scholar
• Petta S, Camma C, Di Marco V, et al. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol. 2008;103:1136–1144.
   PubMed Web of Science ®Google Scholar
• Hindi M, Levy C, Couto CA, et al. Primary biliary cirrhosis is more severe in overweight patients. J Clin Gastroenterol. 2013;47:e28–e32.
   PubMed Web of Science ®Google Scholar
• Naveau S, Giraud V, Borotto E, et al. Excess weight risk factor for alcoholic liver disease. Hepatology. 1997;25:108–111.
   PubMed Web of Science ®Google Scholar
• Schult A, Eriksson H, Wallerstedt S, et al. Overweight and hypertriglyceridemia are risk factors for liver cirrhosis in middle-aged Swedish men. Scand J Gastroenterol. 2011;46:738–744.
   PubMed Web of Science ®Google Scholar
• Bengtsson C, Blohme G, Hallberg L, et al. The study of women in Gothenburg 1968-1969–a population study. General design, purpose and sampling results. Acta Med Scand. 1973;193:311–318.
   PubMedGoogle Scholar
• Lissner L, Skoog I, Andersson K, et al. Participation bias in longitudinal studies: experience from the Population Study of Women in Gothenburg, Sweden. Scand J Prim Health Care. 2003;21:242–247.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24:659–667.
   PubMed Web of Science ®Google Scholar
• Lapidus L, Bengtsson C, Larsson B, et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed). 1984;289:1257–1261.
   PubMed Web of Science ®Google Scholar
• Lear SA, James PT, Ko GT, et al. Appropriateness of waist circumference and waist-to-hip ratio cutoffs for different ethnic groups. Eur J Clin Nutr. 2010;64:42–61.
   PubMed Web of Science ®Google Scholar
• Dalton M, Cameron AJ, Zimmet PZ, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003;254:555–563.
   PubMed Web of Science ®Google Scholar
• Lapidus L, Bengtsson C, Bergfors E, et al. Alcohol intake among women and its relationship to diabetes incidence and all-cause mortality: the 32-year follow-up of a population study of women in Gothenburg, Sweden. Diabetes Care. 2005;28:2230–2235.
   PubMed Web of Science ®Google Scholar
• Harder VS, Stuart EA, Anthony JC. Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research. Psychol Methods. 2010;15:234–249.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Abdelmalek MF, Unalp-Arida A, et al. Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic Fatty liver disease. Clin Gastroenterol Hepatol. 2010;8:1062–1069.
   PubMed Web of Science ®Google Scholar
• Subramanian V, Johnston RD, Kaye P, et al. Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013;37:455–463.
   PubMed Web of Science ®Google Scholar
• Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316:129–139.
   PubMed Web of Science ®Google Scholar
• Fontana L, Eagon JC, Trujillo ME, et al. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56:1010–1013.
   PubMed Web of Science ®Google Scholar
• Schaffler A, Scholmerich J, Buchler C. Mechanisms of disease: adipocytokines and visceral adipose tissue–emerging role in nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2:273–280.
   PubMedGoogle Scholar
• Fan JG, Farrell GC. VAT fat is bad for the liver, SAT fat is not! J Gastroenterol Hepatol. 2008;23:829–832.
   PubMed Web of Science ®Google Scholar
• Bjorkelund C, Lissner L, Andersson S, et al. Reproductive history in relation to relative weight and fat distribution. Int J Obes Relat Metab Disord. 1996;20:213–219.
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Ciaponi M, Cappagli B, et al. Climacteric modifications in body weight and fat tissue distribution. Climacteric. 1999;2:37–44.
   PubMedGoogle Scholar
• Reddy Kilim S, Chandala SR. A comparative study of lipid profile and oestradiol in pre- and post-menopausal women. J Clin Diagn Res. 2013;7:1596–1598.
   PubMedGoogle Scholar
• Ryoo JH, Suh YJ, Shin HC, et al. Clinical association between non-alcoholic fatty liver disease and the development of hypertension. J Gastroenterol Hepatol. 2014;29:1926–1931.
   PubMed Web of Science ®Google Scholar
• Lopez-Suarez A, Guerrero JM, Elvira-Gonzalez J, et al. Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase. Eur J Gastroenterol Hepatol. 2011;23:1011–1017.
   PubMed Web of Science ®Google Scholar
• Dixon JB, Bhathal PS, O’Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001;121:91–100.
   PubMed Web of Science ®Google Scholar
• Donati G, Stagni B, Piscaglia F, et al. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut. 2004;53:1020–1023.
   PubMed Web of Science ®Google Scholar
• Chen L, Smith GD, Harbord RM, et al. Alcohol intake and blood pressure: a systematic review implementing a Mendelian randomization approach. PLoS Med. 2008; 5:e52.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
   PubMed Web of Science ®Google Scholar
• Bengtsson C, Allebeck P, Lissner L, et al. Alcohol habits in Swedish women: observations from the population study of women in Gothenburg, Sweden 1968–1993. Alcohol Alcohol. 1998;33:533–540.
   PubMed Web of Science ®Google Scholar
• Ratziu V, Bellentani S, Cortez-Pinto H, et al. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010;53:372–384.
   PubMed Web of Science ®Google Scholar